4 completed, 1 recruiting, 1 unknown. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Henipavirus Infections: new trials by email Literature Review of Henipavirus Infections trials Research Report on Henipavirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects PHV02, Lactated Ringer's - Nipah Virus Infection | Phase 1 | Completed | Public Health Vaccines LLC | 120 | 2024-01-26 | 2025-06-08 |
| Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults mRNA -1215 - Nipah Virus Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2022-07-11 | 2025-10-23 |
| A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects PHV02, Placebo - Nipah Virus Infection | Phase 1 | Completed | Public Health Vaccines LLC | 60 | 2022-01-10 | 2024-10-24 |
| Safety and Immunogenicity of a Nipah Virus Vaccine HeV-sG-V, Normal Saline Placebo - Nipah Virus Infection | Phase 1 | Completed | Auro Vaccines LLC | 192 | 2020-02-18 | 2022-11-17 |
| Community Intervention to Prevent Nipah Spillover Ask people not to drink raw sap, Ask people not to drink sap or drink sap from skirt protected trees, No Intervention - Human NiV Infection | Phase 1 / Phase 2 | Unknown | International Centre for Diarrhoeal Disease Research, Bangladesh | 7782 | 2012-11-10 | 2021-05-25 |
Zoonoses (2) · Adenoviridae Infections (1) · Arenaviridae Infections (1) · Brucellosis (1) · Bunyaviridae Infections (1) · Caliciviridae Infections (1) · Chickenpox (1) · Chikungunya Fever (1) · Chlamydia Infections (1) · Communicable Diseases (1) · Dengue (1) · Elephantiasis, Filarial (1) · Encephalitis, Japanese (1) · Encephalitis, Tick-Borne (1)
Infections (6) · Mononegavirales Infections (6) · RNA Virus Infections (6) · Virus Diseases (6) · Paramyxoviridae Infections (5) · Animal Diseases (2) · Adenophorea Infections (1) · Alphavirus Infections (1) · Arbovirus Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bordetella Infections (1) · Brain Diseases (1) · Burkholderia Infections (1) · Central Nervous System Diseases (1)
Ringer's Lactate (1)
Public Health Vaccines LLC (2) · Auro Vaccines LLC (1) · Institut Pasteur du Cambodge (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (4) · Bangladesh (1) · Cambodia (1)
Carlos Fierro, MD (1) · Claude Flamand, Ph.D. (1) · Gray P Heppner, MD (1) · Joan Fusco, PhD (1) · Lesia K Dropulic, M.D. (1) · Robert W. Frenck Jr., MD (1) · Thomas Monath, MD, FASTMH (1) · Thomas P Monath, MD (1)